TELA Bio, Inc.

Informe acción NasdaqGM:TELA

Capitalización de mercado: US$138.1m

Salud financiera de hoja de balance de TELA Bio

Salud financiera controles de criterios 4/6

TELA Bio tiene un patrimonio de los accionistas total de $18.9M y una deuda total de $40.5M, lo que sitúa su ratio deuda-patrimonio en 214.6%. Sus activos y pasivos totales son $78.0M y $59.2M respectivamente.

Información clave

282.7%

Ratio deuda-patrimonio

US$40.67m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$37.14m
PatrimonioUS$14.38m
Total pasivoUS$57.45m
Activos totalesUS$71.84m

Actualizaciones recientes sobre salud financiera

Recent updates

Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

May 29
Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

May 23
TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 24
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

Mar 08
Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Oct 07
TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

Jul 31
Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

TELA Bio: Tailwinds In Hernia Repair Market And Promising Clinical Data To Drive Accelerating Adoption

Oct 02

Tela Bio prices $32M common stock offering

Aug 16

Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

May 12
Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

TELA Bio - Follow Up With Management

Jan 14

Our First Look At TELA Bio

Nov 04

TELA Bio Plugging Away

Oct 25

TELA Bio (TELA) Investor Presentation - Slideshow

May 26

Bearish: Analysts Just Cut Their TELA Bio, Inc. (NASDAQ:TELA) Revenue and EPS estimates

Mar 30
Bearish: Analysts Just Cut Their TELA Bio, Inc. (NASDAQ:TELA) Revenue and EPS estimates

Health Check: How Prudently Does TELA Bio (NASDAQ:TELA) Use Debt?

Feb 12
Health Check: How Prudently Does TELA Bio (NASDAQ:TELA) Use Debt?

TELA Bio guides Q4 and FY20 revenue below consensus

Jan 14

TELA Bio EPS misses by $0.09, beats on revenue

Nov 11

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($71.7M) de TELA superan a sus pasivos a corto plazo ($17.0M).

Pasivo a largo plazo: Los activos a corto plazo de TELA ($71.7M) superan a sus pasivos a largo plazo ($42.2M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (24.5%) de TELA se considera satisfactorio.

Reducción de la deuda: TELA tenía patrimonio neto negativo hace 5 años, pero ahora es positivo y, por lo tanto, ha mejorado.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: TELA tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: TELA tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 14% cada año


Descubre empresas con salud financiera